ERCC1: impact in multimodality treatment of upper gastrointestinal cancer (Q37818224)

23 August 2017

1 reference

title

ERCC1: impact in multimodality treatment of upper gastrointestinal cancer (English)

1 reference

23 August 2017

4

Ute Warnecke-Eberz

1 reference

23 August 2017

Elfriede Bollschweiler

series ordinal

2

object named as

Elfriede Bollschweiler

1 reference

23 August 2017

1

Ralf Metzger

1 reference

23 August 2017

3

Arnulf H Hölscher

1 reference

23 August 2017

language of work or name

English

0 references

publication date

1 November 2010

1 reference

23 August 2017

1 reference

23 August 2017

volume

6

1 reference

23 August 2017

issue

11

1 reference

23 August 2017

page(s)

1735-1749

1 reference

Global cancer statistics in the year 2000.

23 August 2017

cites work

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.140

Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.140

Histologic tumor type and the rate of complete response after neoadjuvant therapy for esophageal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.140

Histomorphologic tumor regression and lymph node metastases determine prognosis following neoadjuvant radiochemotherapy for esophageal cancer: implications for response classification

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.140

ERCC1 mRNA levels complement thymidylate synthase mRNA levels in predicting response and survival for gastric cancer patients receiving combination cisplatin and fluorouracil chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.140

Combined GADD45A and thymidine phosphorylase expression levels predict response and survival of neoadjuvant-treated gastric cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.140

Molecular mechanisms of resistance and toxicity associated with platinating agents

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.140

Cisplatin: mode of cytotoxic action and molecular basis of resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.140

Determinants of chemosensitivity in gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.140

The emerging role of DNA repair proteins as predictive, prognostic and therapeutic targets in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.140

Cancer pharmacogenomics: role of DNA repair genetic polymorphisms in individualizing cancer therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.140

The DNA damage response: ten years after

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.140

ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.140

Platinum resistance: the role of DNA repair pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.140

Novel strategies for reversing platinum resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.140

Increased nucleotide excision repair in cisplatin-resistant ovarian cancer cells: role of ERCC1-XPF.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.140

Oxaliplatin: a review of preclinical and clinical studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.140

High sensitivity of BRCA1-deficient mammary tumors to the PARP inhibitor AZD2281 alone and in combination with platinum drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.140

Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.140

Ionizing radiation causes a dose-dependent release of transforming growth factor alpha in vitro from irradiated xenografts and during palliative treatment of hormone-refractory prostate carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.140

Instability and decay of the primary structure of DNA

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.140

Proceedings of a workshop on DNA adducts: biological significance and applications to risk assessment Washington, DC, April 13-14, 2004.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.140

The 8,5'-cyclopurine-2'-deoxynucleosides: candidate neurodegenerative DNA lesions in xeroderma pigmentosum, and unique probes of transcription and nucleotide excision repair

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.140

Cancer in xeroderma pigmentosum and related disorders of DNA repair

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.140

Transcription-coupled repair and premature ageing

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.140

Xeroderma pigmentosum, trichothiodystrophy and Cockayne syndrome: a complex genotype-phenotype relationship

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.140

A summary of mutations in the UV-sensitive disorders: Xeroderma pigmentosum, Cockayne syndrome, and trichothiodystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.140

Action of DNA repair endonuclease ERCC1/XPF in living cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.140

DNA Damage, Aging, and Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.140

Molecular mechanisms of mammalian global genome nucleotide excision repair.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.140

Transcription-coupled nucleotide excision repair in mammalian cells: molecular mechanisms and biological effects

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.140

Subpathways of nucleotide excision repair and their regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.140

The Y-family DNA polymerase kappa (pol kappa) functions in mammalian nucleotide-excision repair

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.140

Sealing of chromosomal DNA nicks during nucleotide excision repair requires XRCC1 and DNA ligase III alpha in a cell-cycle-specific manner

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.140

Structure of the XPC binding domain of hHR23A reveals hydrophobic patches for protein interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.140

Solution structure and backbone dynamics of the XPC-binding domain of the human DNA repair protein hHR23B.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.140

Crystal structure and DNA binding functions of ERCC1, a subunit of the DNA structure-specific endonuclease XPF-ERCC1

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.140

The structure of the human ERCC1/XPF interaction domains reveals a complementary role for the two proteins in nucleotide excision repair

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.140

Structure of an XPF endonuclease with and without DNA suggests a model for substrate recognition.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.140

Conserved XPB core structure and motifs for DNA unwinding: implications for pathway selection of transcription or excision repair

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.140

Structural basis for the recruitment of ERCC1-XPF to nucleotide excision repair complexes by XPA

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.140

Activity of individual ERCC1 and XPF subunits in DNA nucleotide excision repair

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.140

Mapping of interaction domains between human repair proteins ERCC1 and XPF

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.140

Biophysical characterization of the interaction domains and mapping of the contact residues in the XPF-ERCC1 complex.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.140

Analysis of the XPA and ssDNA-binding surfaces on the central domain of human ERCC1 reveals evidence for subfunctionalization

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.140

The helix-hairpin-helix DNA-binding motif: a structural basis for non-sequence-specific recognition of DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.140

Repair of an interstrand DNA cross-link initiated by ERCC1-XPF repair/recombination nuclease.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.140

The structure-specific endonuclease Ercc1-Xpf is required to resolve DNA interstrand cross-link-induced double-strand breaks

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.140

ERCC1/XPF removes the 3' overhang from uncapped telomeres and represses formation of telomeric DNA-containing double minute chromosomes

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.140

XPF nuclease-dependent telomere loss and increased DNA damage in mice overexpressing TRF2 result in premature aging and cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.140

XPF with mutations in its conserved nuclease domain is defective in DNA repair but functions in TRF2-mediated telomere shortening

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.140

Specific association between the human DNA repair proteins XPA and ERCC1

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.140

Mutations in XPA that prevent association with ERCC1 are defective in nucleotide excision repair

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.140

DNA repair gets physical: mapping an XPA-binding site on ERCC1

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.140

Sequential assembly of the nucleotide excision repair factors in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.140

The comings and goings of nucleotide excision repair factors on damaged DNA

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.140

The XPA-binding domain of ERCC1 is required for nucleotide excision repair but not other DNA repair pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.140

Purification and characterization of the XPF-ERCC1 complex of human DNA repair excision nuclease

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.140

How nucleotide excision repair protects against cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.140

Expression of nucleotide excision repair genes and the risk for squamous cell carcinoma of the head and neck

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.140

Genetic variation and exposure related risk estimation: will toxicology enter a new era? DNA repair and cancer as a paradigm

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.140

Polymorphisms in DNA repair and environmental interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.140

No association of ERCC1 C8092A and T19007C polymorphisms to cancer risk: a meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.140

Two regions in chromosome 19q13.2-3 are associated with risk of lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.140

Polymorphisms/haplotypes in DNA repair genes and smoking: a bladder cancer case-control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.140

DNA repair gene ERCC1 and ERCC2/XPD polymorphisms and risk of squamous cell carcinoma of the head and neck

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.140

Genetic polymorphisms in the nucleotide excision repair pathway and lung cancer risk: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.140

DNA repair polymorphisms and cancer risk in non-smokers in a cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.140

ERCC1 and ERCC2 expression in malignant tissues from ovarian cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.140

ERCC1 and XRCC1 gene polymorphisms predict response to neoadjuvant radiochemotherapy in esophageal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.140

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.140

ERCC1 predicting chemoradiation resistance and poor outcome in oesophageal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.140

Patients with ERCC1-negative locally advanced esophageal cancers may benefit from preoperative chemoradiotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.140

Tumour regression and ERCC1 nuclear protein expression predict clinical outcome in patients with gastro-oesophageal cancer treated with neoadjuvant chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.140

Prognostic value of expression of ERCC1, thymidylate synthase, and glutathione S-transferase P1 for 5-fluorouracil/oxaliplatin chemotherapy in advanced gastric cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.140

Increased ERCC expression correlates with improved outcome of patients treated with cisplatin as an adjuvant therapy for curatively resected gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.140

A randomized phase III study of adjuvant platinum/docetaxel chemotherapy with or without radiation therapy in patients with gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.140

Biomarker analysis in stage III-IV (M0) gastric cancer patients who received curative surgery followed by adjuvant 5-fluorouracil and cisplatin chemotherapy: epidermal growth factor receptor (EGFR) associated with favourable survival

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.140

High specificity of quantitative excision repair cross-complementing 1 messenger RNA expression for prediction of minor histopathological response to neoadjuvant radiochemotherapy in esophageal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.140

TaqMan low-density arrays and analysis by artificial neuronal networks predict response to neoadjuvant chemoradiation in esophageal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.140

High gene expression of TS1, GSTP1, and ERCC1 are risk factors for survival in patients treated with trimodality therapy for esophageal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.140

ERCC1 RNA expression in peripheral blood predicts minor histopathological response to neoadjuvant radio-chemotherapy in patients with locally advanced cancer of the esophagus.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.140

Association of pretherapeutic expression of chemotherapy-related genes with response to neoadjuvant chemotherapy in Barrett carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.140

Impacts of excision repair cross-complementing gene 1 (ERCC1), dihydropyrimidine dehydrogenase, and epidermal growth factor receptor on the outcomes of patients with advanced gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.140

ERCC1 mRNA levels and survival of advanced gastric cancer patients treated with a modified FOLFOX regimen

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.140

Cisplatin pharmacogenetics, DNA repair polymorphisms, and esophageal cancer outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.140

Downregulation of TS, DPD, ERCC1, GST-Pi, EGFR, and HER2 gene expression after neoadjuvant three-modality treatment in patients with esophageal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.140

ERCC1 codon 118 C→T polymorphism associated with ERCC1 expression and outcome of FOLFOX-4 treatment in Asian patients with metastatic colorectal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.140

ERCC1 polymorphism, expression and clinical outcome of oxaliplatin-based adjuvant chemotherapy in gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.140

Pharmacogenetic analyses of a phase III trial in metastatic gastroesophageal adenocarcinoma with fluorouracil and leucovorin plus either oxaliplatin or cisplatin: a study of the arbeitsgemeinschaft internistische onkologie

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.140

Polymorphisms of the NER pathway genes, ERCC1 and XPD are associated with esophageal adenocarcinoma risk

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.140

Polymorphisms in MGMT and DNA repair genes and the risk of esophageal adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.140

Genetic susceptibility to esophageal cancer: the role of the nucleotide excision repair pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.140

DNA polymorphism and risk of esophageal squamous cell carcinoma in a population of North Xinjiang, China

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.140

CyclinD1 and interleukin-1 receptor antagonist polymorphisms are associated with prognosis in neoadjuvant-treated gastric carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.140

BRCA1 and XRCC1 polymorphisms associated with survival in advanced gastric cancer treated with taxane and cisplatin

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.140

Clinical significance of the gene expression profile in residual tumor cells after neoadjuvant chemo-radiotherapy for esophageal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.140

Polymorphisms in Genes of Nucleotide and Base Excision Repair: Risk and Prognosis of Colorectal Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.10.140

21 January 2018

Identifiers

DOI

10.2217/FON.10.140

1 reference

23 August 2017

1 reference